Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific, J&J Dwell In Separate REALITY; Data Swamps ACC

This article was originally published in The Gray Sheet

Executive Summary

Johnson & Johnson is emphasizing Cypher's low thrombosis rates after the sirolimus-eluting stent failed to show clinical superiority over Boston Scientific's Taxus

You may also be interested in...



REALITY Trial Investigators’ Expectations May Have Been Unrealistic – JAMA

Investigators in the Johnson & Johnson-sponsored REALITY drug-eluting stent trial should not have expected large differences in outcomes between J&J's Cypher and Boston Scientific's Taxus, according to an editorial in the Feb. 22 issue of the Journal of the American Medical Association

REALITY Trial Investigators’ Expectations May Have Been Unrealistic – JAMA

Investigators in the Johnson & Johnson-sponsored REALITY drug-eluting stent trial should not have expected large differences in outcomes between J&J's Cypher and Boston Scientific's Taxus, according to an editorial in the Feb. 22 issue of the Journal of the American Medical Association

Warning Letter Should Not Hinder Taxus Liberté Approval – Boston Scientific

Boston Scientific estimates it will be ready by June for FDA to re-inspect its facilities to confirm that the quality-control problems cited in a sweeping Jan. 25 warning letter have been fixed

Related Content

UsernamePublicRestriction

Register

MT021755

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel